Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

doi:10.1016/j.jhep.2013.04.007

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

Journal of hepatology - 1 Aug 2013

Mangia Alessandra, Santoro Rosanna, Copetti Massimiliano, Massari Marco, Piazzolla Valeria, Spada Enea, Cappucci Giuseppe, Missale Gabriele, Mottola Leonardo, Agostinacchio Ernesto, Mauro Lazzaro di, Zuccaro Ornella, Maio Patrizia, Pellegrini Fabio, Folgori Antonella, Ferrari Carlo

Abstract excerpt

BACKGROUND & AIMS: The lack of consensus on the optimal timing, regimen, and duration of treatment, in patients with acute HCV infection, stimulates the research on both favourable outcome predictors and individualized treatment regimens. This study aimed at investigating the impact of IL28B SNP rs12979860 alone or in combination with HLA class II alleles in both predicting spontaneous viral clearance and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class II

Share to HLA-DQ beta-Chains

Share to HLA-DRB1 Chains

Share to Interferons

Share to Interleukins

Share to Jaundice

Share to Precision Medicine

Source

Open in PubMed

Identifiers

PMID: 23587473
DOI: 10.1016/j.jhep.2013.04.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.PMID 23587473Read ↗

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.Semantic proximity Read ↗

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.Semantic proximity Read ↗

Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.Semantic proximity Read ↗

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.Semantic proximity Read ↗

Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients.Semantic proximity Read ↗

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.Semantic proximity Read ↗

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.Semantic proximity Read ↗

Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review.Semantic proximity Read ↗

Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.Semantic proximity Read ↗

IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.Semantic proximity Read ↗

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.